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In dipper patients the LF/HF was higher during daytime compared to
the night ( 3.3 ± 0.5 vs 2.05 ± 0.27, p = 0.0041) where as no significant
difference was noticed in non dipper patients (3.3 ± 0.24 vs 2.7 ± 0.33, p
= NS ).
Conclusion: these results suggest that despite similar global HRV and
HRT parameters in dippers and non dippers, non dipper patients have an
imbalance of the circadian sympathic-vagal tonus pattern with a high nocturnal
sympathic tonus. These data may partially explain the higher incidence of car-
diovascular events reported in non dipper patients.
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Purpose: Hypertension is an important predisposing factor for the occur-
rence of acute type A aortic dissection (AD) or intramural hematoma (AH),
both conditions requiring urgent surgical treatment. It is also a recognized
pejorative factor for morbidity and mortality after aortic surgery. Despite of
this, the assessment of blood pressure (BP) control after surgical treatment of
AD or AH is little studied.
Method: We performed a pilot study among patients treated by surgery for
AD or AH between 1990 and 2005 in our institution. Clinical BP measurement
and 24 hours ambulatory BP monitoring (ABPM) were performed especially
for the study.
Results: Among the 217 patients of the cohort, 81 were died. We ana-
lyzed the results of the first 43 surviving patients (34 men, mean age = 66 +
10 years). Clinical BP parameters were: systolic BP = 148 + 24 mmHg
and diastolic BP = 81 + 11mmHg. ABPM results were: 24-hours systolic BP
= 127 + 15 mmHg and 24-hour diastolic BP = 70 + 9 mmHg). The mean
number of drugs for hypertension was 2.6 + 1.2. Thirty two patients (72%)
received a beta-blocker and 20 patients (46%) an angiotensin-converting
enzyme inhibition. At mean follow-up of 14 years, Hypertension was diag-
nosed in 34 (79%), 26 (60%) of the patients using respectively clinic and
ABPM.
Conclusion: In this very high cardiovascular risk population, only 21%
and 40% patients were normotensives in clinic and in ABPM respectively.
This result must be improved using a more systematic BP follow-up by
cardiologists, particularly by using systematically ABPM. Moreover, the
number of antihypertensive drugs must be increased to improve the BP
control.
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While the links between high blood pressure and heart failure (HF) are well
known, the clinical profiles of hypertensive patients (pts) according to measure
of left ventricular (LV) ejection fraction (EF) remain poorly investigated. O-
PREDICT 2 was a multicentre observational study conducted among 1537
general practitioners who classified 4427 hypertensive outpatients (pts) (mean
age 72±9 years; 66% males)according to the presence (Group 1, 2969 Pts) or
absence (Group 2, age > 65 years) of a history of clinical HF. The study cohort
included 2052 (46.4%) pts with an available measure of LVEF, 1713 (58%)
from group 1 and 350 from group 2.
Results: In group 1, 677 (39.5%) pts had a reduced EF ≤ 40% (1A) and
1036 (60.5%) had a preserved EF > 40% (1B), while, in group 2, 330
(94.3%) had a preserved EF. When comparing groups 1A, 1B and 2, a sig-
nificant difference (p<.05) was found for history of hospitalization for HF
(70.3%, 59.2% and 0%, respectively), SBP ≥ 140 mmHg (35%, 47.7% and
53.6%), coronary artery disease (52.2%, 40.4% and 15.2%), and myocardial
infarction (69.2%, 52.3% and 46.8%). Incidence of atrial fibrillation (AF)
was 11% in group 2 while in groups 1A and 1B it differed according to the
NYHA functional class, reaching respectively 50.1% and 62.9% of the pts
in class II, and 39.5% and 24.6% of the pts in class III. Reduced EF was
more frequent in male (74% in group 1A vs. 64.2% in group 1B and 63.6%
in group 2) than in female (26% vs. 35.8% and 36.4%, respectively). LV
hypertrophy, cardiovascular disease, renal failure or arteriopathy, were
evenly distributed in groups 1A and 1B.
Conclusion: Among hypertensive pts with a clinical history of HF, pts
with preserved HF are more often female and presented with AF, while pts
with systolic HF are more often hospitalized or presented with a history of
coronary artery disease. However, even in case of preserved EF, the rates
of hospitalizations and myocardial infarction remain markedly elevated
(> 50%)
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Objective: In this study we investigated the interest to detect masked
hypertension (MH) in a population of patients with no prior history of hyper-
tension, at very high cardiovascular risk and who received hypotensive medi-
cations prescribed for their vascular disease, as angiotensin- converting
enzyme inhibitor (ACE).
Design and Method: In this prospective study, 38 patients were send to
our unit for the realisation of a coronarography or an arteriography. Subjects
have no prior history of hypertension, with a blood pressure (BP) at admission
under 140/90 mmHg, and documented vascular disease. They underwent a 24-
h ambulatory BP monitoring(ABMP) after discharge. Subjects who showed
normotension at admission and an ambulatory BP under 125/80 mmHg on the
24-h ABMP were considered as normotensive (NT). Subjects who showed
normotension at admission and an ambulatory BP upper or equal to 125/
80mmHg were defined as MH.
Results: MH was found in 11 patients, represented 28.9 % of our popula-
tion. The prevalence of MH was significantly higher in subjects whose mean
systolic BP and mean diastolic BP (127.2 mmHg vs 115.8 mmHg, p=0.002
and 76.1 mmHg vs 66.6 mmHg, p=0.01) during the hospitalisation than the
confirmed NT did. At admission the systolic BP and the pulse pressure tend
to be higher in the MH group than in the NT group ( 127.5 mmHg vs 121
mmHg, p= 0.07 and 54.5 mmHg vs 46.7 mmHg,p=0.06). The first measure-
ment of blood pressure of the 24-h ABPM, who was considered as a pressure
of consultation, was significantly higher in the MH group than in the NT
group (140 mmHg vs 121 mmHg, p = 0.001 for the systolic BP and 84 mmHg
vs 74 mmHg, p=0.03, for the diastolic BP).
Conclusions: MH is frequent in our population with a documented vas-
cular disease under medication, with no prior history of hypertension. The
screening of MH hypertension in this population seems to be necessary. The
pre hypertensive rank seems to be a good predictor of MH. 
